Herein, our study suggests that SOCS3 and A20 may serve as prognostic biomarkers in CCA, and our results support the hypothesis that A20 enhances JAK/STAT signaling in CCA by down-regulating SOCS3. The gene discussed is SOCS3; the disease is cholangiocarcinoma.